Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is a publicly traded Healthcare sector company. As of July 21, 2026, MRVI trades at $7.11 with a market cap of $1.07B and a P/E ratio of -9.99. MRVI moved -2.22% today. Year to date, MRVI is +113.76%; over the trailing twelve months it is +187.65%. Its 52-week range spans $1.67 to $7.31. Analyst consensus is buy with an average price target of $5.67. Rallies surfaces MRVI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MRVI moved -2.22% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $7.11 |
| Market Cap | $1.07B |
| P/E Ratio | -9.99 |
| EPS | $-0.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.31 |
| 52-Week Low | $1.67 |
| Volume | 189.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $204.73M |
| Net Income | $-184.29M |
| Gross Margin | 29.29% |
5 analysts cover MRVI: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.67.